Blog
RSS FeedPosted by Michael Wonder on 19 Aug 2020
Mylan brings critical access to the multiple sclerosis community by launching a more affordable treatment option through a first generic to Tecfidera
19 August 2020 - Mylan today announced the launch of the first FDA approved therapeutically equivalent, substitutable generic of Biogen's ...
Posted by Michael Wonder on 13 Aug 2020
Drug prices fall in Switzerland but generics remain expensive
13 August 2020 - Switzerland is narrowing the gap with other European countries when it comes to the cost of medicines. ...
Posted by Michael Wonder on 14 Jul 2020
Teva announces availability of ProAir Digihaler (salbutamol sulphate 117 mcg) inhalation powder for patients with asthma and COPD
13 July 2020 - First and only digital rescue inhaler with built-in sensors now available by prescription to patients in the ...
Posted by Michael Wonder on 16 Jun 2020
Supreme Court will not hear generic drug price fixing discovery dispute
16 June 2020 - The U.S. Supreme Court on Monday declined to hear generic drug makers’ challenge to a court ...
Posted by Michael Wonder on 25 May 2020
First generic version of Gilead’s remdesivir will be sold by a Bangladesh drug maker
22 May 2020 - A drug maker in Bangladesh has become the first company to sell a generic version of ...
Posted by Michael Wonder on 19 May 2020
CEO tapped by Trump to make generic drugs during pandemic has a dicey track record
19 May 2020 - As the chief executive of Phlow, the new company awarded $354 million by the federal government ...
Posted by Michael Wonder on 19 May 2020
Teva Canada secures salbutamol inhalers from its global supply chain to mitigate shortage in Canadian market
19 May 2020 - Teva Canada to be first company to import emergency supply of salbutamol inhalers - providing access to ...
Posted by Michael Wonder on 18 May 2020
The coronavirus exposed the US' reliance on India for generic drugs. But that supply chain is ultimately controlled by China
17 May 2020 - Sarah Thebarge, a 41-year-old physician assistant living in San Francisco, takes a pill every day to ...
Posted by Michael Wonder on 15 May 2020
A drug company wagers the U.S. won’t dare charge it with crimes
15 May 2020 - Teva, the world’s largest maker of generic drugs, recently pulled out of settlement talks with the Justice ...
Posted by Michael Wonder on 08 May 2020
The pandemic is a chance to revamp India’s pharmaceutical industry
9 May 2020 - Companies could switch from primarily making generics to producing higher-margin licensed drugs. ...
Posted by Michael Wonder on 07 May 2020
Generic drug maker admits to fixing prices for cholesterol medication
7 May 2020 - For conspiring to inflate drug prices, Apotex will pay $24 million and cooperate with the Justice Department’s ...
Posted by Michael Wonder on 25 Apr 2020
Maker of drug touted as coronavirus cure accuses China of gouging
24 April 2020 - Hydroxychloroquine controversially pushed by Trump as COVID-19 remedy. ...
Posted by Michael Wonder on 15 Apr 2020
Product specific guidances for chloroquine phosphate and hydroxychloroquine sulphate
13 April 2020 - The FDA plays a critical role in protecting the United States from threats including emerging infectious ...
Posted by Michael Wonder on 08 Apr 2020
FDA approves first generic of a commonly used albuterol/salbutamol inhaler to treat and prevent bronchospasm
8 April 2020 - The U.S. FDA today approved the first generic of Proventil HFA (albuterol sulphate/salbutamol sulphate) metered dose inhaler, ...
Posted by Michael Wonder on 30 Mar 2020
Trump administration in talks with India to avoid U.S. drug supply shortage
31 March 2020 - India, the top source of generic drugs and ingredients, has restricted exports but the U.S. wants exemptions ...